The results demonstrated that DIO3OS was significantly enriched in the nuclear fraction, revealing that DIO3OS could involve in the development of osteosarcoma in the nuclear fraction (Fig. 6B). The gene discussed is DIO3OS; the disease is osteosarcoma.